Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Longevity Health Holdings, Inc.: Filing of Certificate of Designation for Series A Convertible Voting Preferred Stock (effective 2023-08-09).
- Change
- charter amendment
- Effective
- 2023-08-09
Exact text from the filing
In connection with the Closing, on August 9, 2023, the Company filed the Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Voting Preferred Stock (the “ Certificate of Designation ”) with the Secretary of State of Delaware in accordance with Section 151(a) of the Delaware General Corporation Law.
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Longevity Health Holdings, Inc. completed an acquisition involving Axolotl Biologix, Inc. for the Company issued 3,845,337 shares of its common stock, par value $0.0001 per share (“ Common Stock ”), and 4,243 shares of a newly designated series of Series (closed 2023-08-09).
- Action
- acquisition
- Counterparty
- Axolotl Biologix, Inc.
- Consideration
- the Company issued 3,845,337 shares of its common stock, par value $0.0001 per share (“ Common Stock ”), and 4,243 shares of a newly designated series of Series
- Closing
- 2023-08-09
Exact text from the filing
(“ First Merger Sub ”) and Axolotl Biologix, Inc. (“ Axolotl ”). The Merger Agreement provides for, among other things, the merger of Axolotl with and into Merger Sub, with Axolotl being the surviving corporation of the merger and a direct, wholly owned subsidiary of the Company (the “ Acquisition ”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Longevity Health Holdings, Inc. amended First Amendment to Agreement and Plan of Merger with Carmell Corporation, Aztec Merger Sub, Inc., Axolotl Biologix, Inc. valued at Amendment changes merger structure and waives condition requiring audited financial statements in ex (effective 2023-08-10).
- Action
- amendment
- Agreement
- merger
- Counterparty
- Carmell Corporation, Aztec Merger Sub, Inc., Axolotl Biologix, Inc.
- Value
- Amendment changes merger structure and waives condition requiring audited financial statements in ex
- Effective
- 2023-08-10
Exact text from the filing
On August 10, 2023, Carmell Corporation (the “ Company ”) announced it had entered into that certain First Amendment to Agreement and Plan of Merger (the “ Amendment ”) which amended certain terms of the previously announced Agreement and Plan of Merger (the “ Merger Agreement ”), by and among the Company, Aztec Merger Sub, Inc. (“ First Merger Sub ”) and Axolotl Biologix, Inc. (“ Axolotl ”).
View on SEC.gov